- Home
- FLUX vs RVPH Comparison
FLUX vs RVPH Comparison
Compare FLUX & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLUX
- RVPH
- Stock Information
- Founded
- FLUX N/A
- RVPH 2006
- Country
- FLUX United States
- RVPH United States
- Employees
- FLUX N/A
- RVPH N/A
- Industry
- FLUX Industrial Machinery/Components
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- FLUX Miscellaneous
- RVPH Health Care
- Exchange
- FLUX Nasdaq
- RVPH Nasdaq
- Market Cap
- FLUX 25.4M
- RVPH 26.6M
- IPO Year
- FLUX N/A
- RVPH N/A
- Fundamental
- Price
- FLUX $1.71
- RVPH $0.46
- Analyst Decision
- FLUX Strong Buy
- RVPH Strong Buy
- Analyst Count
- FLUX 2
- RVPH 5
- Target Price
- FLUX $6.00
- RVPH $9.00
- AVG Volume (30 Days)
- FLUX 134.5K
- RVPH 3.2M
- Earning Date
- FLUX 08-15-2025
- RVPH 08-13-2025
- Dividend Yield
- FLUX N/A
- RVPH N/A
- EPS Growth
- FLUX N/A
- RVPH N/A
- EPS
- FLUX N/A
- RVPH N/A
- Revenue
- FLUX $63,074,000.00
- RVPH N/A
- Revenue This Year
- FLUX $11.10
- RVPH N/A
- Revenue Next Year
- FLUX $12.66
- RVPH N/A
- P/E Ratio
- FLUX N/A
- RVPH N/A
- Revenue Growth
- FLUX N/A
- RVPH N/A
- 52 Week Low
- FLUX $1.15
- RVPH $0.30
- 52 Week High
- FLUX $3.78
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- FLUX 44.00
- RVPH 46.82
- Support Level
- FLUX $1.70
- RVPH $0.44
- Resistance Level
- FLUX $2.15
- RVPH $0.53
- Average True Range (ATR)
- FLUX 0.19
- RVPH 0.04
- MACD
- FLUX -0.04
- RVPH 0.02
- Stochastic Oscillator
- FLUX 2.06
- RVPH 56.07
About FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.